Inventor
DECICCO CARL P
US30 patents
⚠️ This page may combine multiple inventors who share the name “DECICCO CARL P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
14 patentsUS7122627B2Oct 17, 2006
Lactam inhibitors of Hepatitis C virus NS3 protease
BRISTOL MYERS SQUIBB CO35 citations92
US6803374B2Oct 12, 2004
Compounds useful for treating hepatitis C virus
BRISTOL MYERS SQUIBB CO41 citations92
US10487086B2Nov 26, 2019
Macrocycles as factor XIa inhibitors
BRISTOL MYERS SQUIBB CO3 citations84
US9802939B2Oct 31, 2017
Macrocycles as factor XIa inhibitors
BRISTOL MYERS SQUIBB CO3 citations84
US7557137B2Jul 7, 2009
Gamma-lactams as beta-secretase inhibitors
BRISTOL MYERS SQUIBB CO9 citations84
US11136327B2Oct 5, 2021
Macrocycles as factor XIA inhibitors
BRISTOL MYERS SQUIBB CO1 citations73
US6610731B2Aug 26, 2003
Lactam metalloprotease inhibitors
BRISTOL MYERS SQUIBB CO8 citations72
US6521436B1Feb 18, 2003
Nucleic acids encoding aggrecan degrading metallo proteases
BRISTOL MYERS SQUIBB CO6 citations71
US12404274B2Sep 2, 2025
Macrocycles as factor xia inhibitors
BRISTOL MYERS SQUIBB CO0 citations62
US9453029B2Sep 27, 2016
Macrocycles as factor XIa inhibitors
BRISTOL MYERS SQUIBB CO2 citations62
US9079918B2Jul 14, 2015
Macrocycles as factor XIa inhibitors
BRISTOL MYERS SQUIBB CO2 citations62
US6753176B2Jun 22, 2004
Aggrecan degrading metallo proteases
BRISTOL MYERS SQUIBB CO2 citations60
US9745313B2Aug 29, 2017
Macrocycles as factor XIa inhibitors
BRISTOL MYERS SQUIBB CO0 citations52
US6884806B2Apr 26, 2005
Bicyclic lactam derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)
BRISTOL MYERS SQUIBB CO2 citations52
BRISTOL MYERS SQUIBB PHARMA CO
9 patentsUS6429213B1Aug 6, 2002
Cyclic hydroxamic acids as metalloproteinase inhibitors
BRISTOL MYERS SQUIBB PHARMA CO95 citations97
US6858626B2Feb 22, 2005
Cyclic hydroxamic acid as metalloproteinase inhibitors
BRISTOL MYERS SQUIBB PHARMA CO66 citations96
US6403632B1Jun 11, 2002
Lactam metalloprotease inhibitors
BRISTOL MYERS SQUIBB PHARMA CO78 citations95
US6451575B1Sep 17, 2002
Aggrecan degrading metallo proteases
BRISTOL MYERS SQUIBB PHARMA CO20 citations90
US6689771B2Feb 10, 2004
Amide derivatives as inhibitors of matrix metalloproteinases, TNF-α, and aggrecanase
BRISTOL MYERS SQUIBB PHARMA CO14 citations84
US6576664B1Jun 10, 2003
Inhibitors of aggrecanase and matrix metalloproteinases for the treatment of arthritis
BRISTOL MYERS SQUIBB PHARMA CO10 citations74
US7049412B1May 23, 2006
Antibodies to aggrecan-degrading metalloprotease and diagnostic methods using same
BRISTOL MYERS SQUIBB PHARMA CO3 citations71
US6989139B2Jan 24, 2006
Matrix metalloproteinase inhibitors
BRISTOL MYERS SQUIBB PHARMA CO5 citations63
US6455522B1Sep 24, 2002
Cyclic sulfonamide derivatives as metalloproteinase inhibitors
BRISTOL MYERS SQUIBB PHARMA CO3 citations63
DU PONT PHARM CO
3 patentsUS6268379B1Jul 31, 2001
Substituted aryl hydroxamic acids as metalloproteinase inhibitors
DU PONT PHARM CO71 citations96
US6376665B1Apr 23, 2002
Amide derivatives as inhibitors of matrix metalloproteinases, TNF-α, and aggrecanase
DU PONT PHARM CO23 citations93
US6281352B1Aug 28, 2001
Macrocyclic compounds as metalloprotease inhibitors
DU PONT PHARM CO10 citations70